Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 8 Model of 4-aminopyridine (4-AP)-induced extracelluarl signal-regulated kinase (ERK) activation in cardiomyocytes. Treatment with 4-AP results in augmentation of L-type calcium (Ca2+) current and calcium transient ([Ca2+]i), leading to the activation of proline-rich tyrosine kinase 2 (Pyk2) and EGFR. Transactivation of EGFR predominantly contributes to ERK activation. EGTA = ethyleneglycoltetraaceticacid.
|
